Today on Outsourcing-Pharma.com   China plant implicated in heparin scare Contract manufacturing news in brief EC 'unlikely to support ban on primate testing' Quotient bolsters its drug development services Intertek buys Irelands Bioclin

Related Industry News   Pfizer expands in inhaled drugs as Nektar cuts back Baxter suspends production of heparin after deaths FDAs proposed rule on labelling touches pre-emption nerve Alpharma pockets $395m for API biz

Breaking News on Outsourcing Pharma
Daily  14-Feb-2008		Forward to a colleague

	Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here Access Full Stories China plant implicated in heparin scare Questions are hanging over the role of a Chinese manufacturing facility in the Baxter heparin scare after it has emerged that the US Food and Drug Administration (FDA) has never inspected the facility... Read Contract manufacturing news in brief DSM, Althea, Laureate Pharma, Albemarle and Patheon have all recently announced new contract manufacturing news... Read EC 'unlikely to support ban on primate testing' The European Commission is unlikely to support an outright ban on the use of non-human primates in research, but has just published a new document which indicates that significant changes to current legislation... Read Quotient bolsters its drug development services Quotient BioResearch, a European analytical and safety evaluation services firm, has bolstered its business with the acquisition of BioDynamics Research... Read Intertek buys Irelands Bioclin UK-based quality and safety services firm Intertek has acquired budding Irish services firm Bioclin Research Laboratories... Read
	All News Headlines for: February | January | December
	Company Profile Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here
	Related Industry News Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Baxter suspends production of heparin after deaths Baxter International has suspended the production of its blood-thinning drug heparin in multi-dose vials, following the deaths of four patients in the USA who were given the drug in high doses... Read FDAs proposed rule on labelling touches pre-emption nerve A proposed rule on labelling changes published by the FDA has re-ignited the reliably inflammable debate over the role of pre-emption in US product liability cases. Critics say the proposal 'shores up the industry's... Read Alpharma pockets $395m for API biz Alpharma has signed a definitive agreement with private equity group 3i for the sale of its active pharmaceutical ingredient (API) business, pocketing $395m in the deal to reinvest in its pharmaceutical and animal... Read Weekly comment Emerging markets 'hot' for VC, says KPMG Emerging markets, headed by China and India are tipped to remain hot destinations for venture capital (VC) investments this year, according to a recent survey by KPMG. Read Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Previous Headlines Missing link to the citric acid cycle found Researchers claim to have found the missing piece in the puzzle of how to artificially recreate the citric acid cycle - an essential part of aerobic respiration. The discovery could lead to plentiful supplies of... Read Pharmaceutical contract services round-up Outsourcing-Pharma compiles the latest in motley pharma services news, including PDI, Sentry Logistics Solutions and HCL... Read Tufts heralds outsourcing as the way of the future The trend towards outsourcing and outside partnering to improve drug development is tipped to continue, with the strategy being heralded as the way of the future in new research produced by the Tufts Center for... Read Icon buys US Phase I base Ireland's Icon has bought itself a Phase I base in the US with the acquisition of Healthcare Discoveries... Read Four Indian vaccine makers have license suspended after failing GMP Four of India's biggest vaccine manufacturers have had their licenses suspended by the Indian government after failing to meet good manufacturing practise (GMP) requirements, according to local media reports... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers Introducing Catalent Pharma Solutions - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com